Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018)

Alnylam Pharmaceuticals has reported Land & Improvements for 3 years, with the latest figure at $9.1 million in Q4 2018.

• For the quarter ending Q4 2018, Land & Improvements changed 0.0% year-over-year to $9.1 million; the trailing twelve-month figure through Dec 2018 stood at $9.1 million (changed 0.0% YoY), and the FY2018 full-year result was $9.1 million, changed 0.0% from the prior year.
• Land & Improvements for Q4 2018 stood at $9.1 million, roughly flat from $9.1 million in the prior quarter.
• The five-year high for Land & Improvements was $9.1 million in Q4 2016, with the low at $9.1 million in Q4 2016.
• Historically, Land & Improvements has averaged $9.1 million across 3 years, with a median of $9.1 million in 2016.
• The largest YoY upside for Land & Improvements was 0.0% in 2017 against a maximum downside of 0.0% in 2017.
• Alnylam Pharmaceuticals' Land & Improvements stood at $9.1 million in 2016, then changed by 0.0% to $9.1 million in 2017, then changed by 0.0% to $9.1 million in 2018.
• The last three Land & Improvements figures came in at $9.1 million (Q4 2018), $9.1 million (Q4 2017), and $9.1 million (Q4 2016), per Business Quant data.